Antisense Oligonucleotides Market Key Players Profile Share and Growth by 2032

Posted by Devid Won on July 31st, 2024

The Reports and Insights, a leading market research company, has recently releases report titled “Antisense Oligonucleotides Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Antisense Oligonucleotides Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Antisense Oligonucleotides Market?

The global antisense oligonucleotides market size reached US$ 2.8 billion in 2023. Looking forward, Reports and Insights expects the market to reach US$ 4.9 billion in 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032.

What are Antisense Oligonucleotides?                                                                                                                                                                            

Antisense oligonucleotides (ASOs) are short, synthetic nucleic acid strands designed to bind specifically to messenger RNA (mRNA) molecules, thereby regulating gene expression. By attaching to their target mRNA, ASOs can inhibit the production of disease-causing proteins, degrade the mRNA, or alter splicing patterns. This targeted approach allows for precise treatment of genetic disorders, viral infections, and some cancers. ASOs are a promising therapeutic strategy due to their specificity, ability to target previously "undruggable" genes, and advancements in their design and delivery.

Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/2216

What are the growth prospects and trends in the Antisense Oligonucleotides industry?

The antisense oligonucleotides (ASOs) market growth is driven by various factors and trends. The antisense oligonucleotides (ASOs) market is expanding quickly due to their potential in treating various genetic disorders, cancers, and viral infections. Growth is fueled by advancements in biotechnology, increased investment in research and development, and a rising number of FDA approvals for ASO-based therapies. North America currently dominates the market due to its robust biopharmaceutical sector and supportive regulatory environment, with significant growth also seen in Europe and Asia-Pacific. Key market players are focusing on strategic collaborations and innovations to improve the efficacy, safety, and delivery of ASO therapies, thereby broadening their therapeutic applications and market presence. Hence, all these factors contribute to antisense oligonucleotides (ASOs) market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

By Therapeutic Areas

• Genetic Disorders
  • Duchenne Muscular Dystrophy (DMD)
  • Spinal Muscular Atrophy (SMA)
  • Familial Hypercholesterolemia
  • Others
• Oncology
• Neurological Disorders
  • Amyotrophic Lateral Sclerosis (ALS)
  • Acquired Immunodeficiency Syndrome (AIDS)
  • Others
• Cardiovascular Diseases
• Ophthalmic
  • Cytomegalovirus Retinitis
  • Others
• Infectious Diseases
• Others

By End-User

• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Research Institutes and Academic Centers
• Others

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia
• Poland
• Benelux
• Nordic
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• South Korea
• ASEAN
• Australia New Zealand
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Argentina

Middle East Africa

• Saudi Arabia
• South Africa
• United Arab Emirates
• Israel
• Rest of MEA

Who are the key players operating in the industry?

The report covers the major market players including:

• Ionis Pharmaceuticals, Inc.
• Sarepta Therapeutics, Inc.
• Biogen
• Isarna Therapeutics GmbH
• Enzon Pharmaceuticals, Inc.
• Bio-Path Holdings, Inc.
• Gene Signal International SA
• GlaxoSmithKline plc
• miRagen Therapeutics, Inc.
• Regulus Therapeutics
• Rexahn Pharmaceuticals, Inc.

View Full Report: https://www.reportsandinsights.com/report/Antisense Oligonucleotides-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

Reports and Insights Business Research Pvt. Ltd.
1820 Avenue M, Brooklyn, NY, 11230, United States
Contact No: +1-(347)-748-1518